Now I have enough information to produce the final consolidated review.

---

## Summary

This paper proposes a three-stage deep learning pipeline for automated hip implant loosening analysis from X-ray images: (1) a fitness check to flag images unsuitable for diagnosis, (2) an encoder-decoder network that segments the implant into 10 clinically defined Charnley and Gruen zones, and (3) a transfer-initialized classifier that assigns each zone a 3-class loosening status (control / loose / not visible). The authors extend the existing Rahman et al. 206-image public dataset with expert zone-level masks and per-zone loosening annotations, report 0.95 Dice for zone segmentation and 98% overall loosening accuracy, and validate on an external blind set of 38 clinical images.

---

## Strengths

- **Zone-level annotation contribution**: The paper creates zone-wise segmentation masks and per-zone loosening labels (an Excel file with 3-class status per zone per image) on top of a dataset that previously contained only binary control/loose labels. This is a genuinely novel and reusable resource. No prior open-source dataset of this kind exists.

- **Task formulation beyond binary classification**: Predicting loosening per Gruen/Charnley zone, rather than a single image-level label, is clinically more informative — it distinguishes stem-level (Gruen) from cup-level (Charnley) involvement and can directly guide revision planning. This framing is a concrete advancement over the cited image-level classifiers.

- **Meaningful external blind test**: The evaluation on 38 unseen clinical images from an orthopedic surgeon, none used in training, is a genuine positive. Dice 0.92 and accuracy 0.93 on a new distribution demonstrates some generalizability. This is notably better than purely in-domain reporting, which is common in small-dataset medical imaging papers.

- **Concrete advantage over the only directly comparable segmentation method**: Alzaid et al. (2024) reported 0.8 Dice for Gruen-only zone segmentation; the proposed method reports 0.94–0.96 Dice for all 10 zones (a harder task). This is the one technically fair and favorable comparison in the paper.

---

## Weaknesses

### Fatal
*None that fully invalidates the paper.*

### Major

- **Evaluation protocol inconsistency undermines all headline numbers.** Section 4 simultaneously states "we used 130 images for training and 57 images for testing" (a fixed 70:30 split) and "we have performed 5-fold cross-validation and the reported results are the average values." These are mutually inconsistent. The confusion matrix in Table 2 has exactly 57 cells (23+1+0+33), which matches the fixed split, not a fold average. If 5-fold CV were actually performed, the confusion matrix would need to be based on the full 187 samples, not 57. This contradiction means the reader cannot determine which protocol produced which numbers, and the claim of reporting "average values" cannot be trusted. This is the most serious issue in the paper because it affects every headline metric.

- **Stage 1 fitness classification is inadequately evaluated.** Only 19 of 206 images are "not fit." Without any augmentation accounting, a classifier predicting "fit" for everything achieves ~90.8% accuracy on this dataset — the paper's 94% figure provides almost no information. No per-class breakdown, sensitivity, or specificity is reported. Since failing to detect an unfit image is the highest-risk error (it passes a bad image to downstream stages), recall for the not-fit class is the clinically critical metric, and it is entirely absent.

- **Table 3's headline comparison is partially invalid.** The paper states it "compares performance of our proposed method with other methods reported in the literature on **the same dataset**." However, Xception (Alirez et al., 2019) and DenseNet (Lawrence et al., 2022) were evaluated on different private datasets — Alirez on 236 images from 15,277 patients; Lawrence on their own data. Only Rahman et al.'s own results (DenseNet201 and Random Forest) are on the same dataset. Claiming superiority over "other methods on the same dataset" while including out-of-distribution baselines in that table is misleading. Furthermore, even the same-dataset comparisons (Rahman et al. methods) involve different supervision regimes: the proposed method uses richer zone-level annotations that the baselines did not have access to, making the comparison a different-supervision result rather than a head-to-head algorithm comparison.

- **Stage 3 inference pipeline is not clearly specified.** Figure 5 and Section 3.2.3 list the "Annotated GroundTruth Excel File" as one of the three inputs to Stage 3. If this ground-truth annotation is required at inference time, the system cannot operate on new images without expert input — eliminating the claim of automation. If the Excel file is only a training-time label source (which is the sensible interpretation), the paper never explicitly states that Stage 3 operates purely on predicted Stage 2 segmentations at inference. This ambiguity makes the 98% loosening accuracy difficult to interpret.

### Minor

- **Confusion matrix labels are inverted.** Table 2 labels "Control" as True Positive and "Loose" as True Negative. In this task, loosening is the condition of interest (the positive class). The actual counts may still support the headline accuracy, but mislabeled confusion matrices undermine confidence in derived precision/recall calculations and raise questions about whether all secondary metrics were computed correctly.

- **No segmentation baseline comparison.** The segmentation architecture is a standard encoder-decoder; the paper provides no comparison against U-Net or any other established architecture on the same data. It is impossible to determine whether the strong Dice scores reflect architectural merit or merely the constrained geometric nature of the zones plus annotation quality.

- **Exponential Logarithmic Loss (Stage 3) is underspecified.** Equation 5 only defines the total loss as the sum of two named sub-components, but never provides the actual exponential or logarithmic transformations for either term. This is insufficient for reproducibility and is not cited as a prior formulation.

- **Single annotator with no inter-rater agreement.** All annotations were created by one orthopedic surgeon. For a task as perceptually subtle as zone-boundary delineation and radiolucency classification, without any inter-rater reliability measurement, the annotations cannot be treated as a gold standard.

- **GradCAM color convention is inverted from standard.** The paper describes "blue reflects the most significant features… red represents the least significant features," which is opposite to standard GradCAM convention (red = highest activation). If the figures actually follow standard convention (which the figure captions in the alt-text appear to suggest), the text description is wrong, casting doubt on interpretability claims.

### Trivial

- **Stage 1 uses a different split (80:20) from Stages 2/3 (70:30)** without justification beyond "due to the limited number of samples." While understandable, this creates three incompatible evaluation protocols within one paper (80:20, 70:30, and the claimed but unverified 5-fold CV).

- **The "Conv1d" labeling in Figure 4** for a 2D image segmentation network is clearly a diagram labeling error (the text correctly describes 2D convolutions), not a methodological problem.

---

## Nice-to-Haves

- A second annotator's labels on a random subset (e.g., 30 images) with Cohen's kappa for both zone boundaries and loosening status would substantially strengthen the dataset contribution.
- Reporting class distributions for the 3-class loosening task (how many zones are loose vs. control vs. not visible) is essential context for interpreting the per-zone metrics.
- Error propagation analysis: what happens to Stage 3 accuracy when Stage 2 produces a Dice score of, say, 0.80 instead of 0.95? Understanding this sensitivity would be important for deployment.
- An end-to-end comparison (skip Stage 2, directly classify zones from the raw image) would validate that the staged design is necessary.

---

## Removed Points

*These points are flagged to be removed; treat them with caution.*

- **"Not yet released" / availability concerns about any cited work**: All reviewers accepted existing citations as valid; none questioned the existence of Rahman et al. dataset or other references.

- **Requesting confidence intervals for 5-fold CV**: Given the dataset is only 57 test images, reporting standard deviations across folds would be desirable but demanding CIs is not standard in this field for such small sets. Retained as a minor concern only because the 5-fold claim itself is inconsistent (not because CIs are lacking per se).

- **"Conv1d is an error for 2D convolution"**: The neutral reviewer flagged this as a potential error. The figure legend says "Conv1d" but the text clearly describes 2D convolutional blocks. This is a diagram labeling inconsistency, not a methodological error; removed from substantive weaknesses.

- **Requesting ethics/IRB statement**: The harsh critic/Spark reviewer flagged the absence of an IRB statement. This is a legitimate concern for clinical data but is a presentation/compliance matter, not a technical or scientific weakness that affects the paper's contributions. Removed from substantive weaknesses.

- **Comparison asymmetry concern (unfair comparison disfavoring baselines)**: One reviewer noted the proposed method benefits from richer supervision. Per the hard rules, if asymmetry favors the baseline (as it would when the prior methods had less supervision), this would be removed. However, here the asymmetry favors the *proposed* method (richer supervision → higher accuracy), so the comparison criticism is retained.

- **"Robustness and repeatability" terminology**: Spark reviewer suggested these terms are overused. The concern about "repeatability" being misused is valid as a writing note but too minor to be a substantive weakness.

---

## Novel Insights

The paper's most interesting contribution is not architectural but rather the task formulation itself: zone-level loosening classification creates a structured, anatomically grounded output space where clinical actionability is intrinsic to the prediction (Gruen zones implicate the stem; Charnley zones implicate the cup). This multi-label structured output design, where each zone has an independently interpretable label rather than a single image-level score, is more clinically meaningful than any prior reported approach on this dataset and could be adopted by future work even with much larger datasets. The "not visible" class design choice is also genuinely thoughtful: rather than forcing a binary decision on occluded zones, the model is designed to flag uncertainty for expert review, which is the correct clinical behavior.

---

## Suggestions

1. **Resolve the 5-fold CV vs. fixed split contradiction explicitly**: Either report results from one clean protocol (recommended: patient-level 5-fold CV on the 187 usable images, reporting mean ± std for all metrics), or remove the 5-fold CV claim entirely and report fixed-split results only.
2. **Report sensitivity/specificity for Stage 1**: Given only 19 not-fit examples, the primary metric must be sensitivity (recall) for the not-fit class, not overall accuracy.
3. **Clarify Stage 3 inference pipeline**: A single sentence in Section 3.2.3 explicitly stating "At inference time, only the original X-ray image and the Stage 2 predicted masks are used as inputs; the Excel file provides training labels only" would resolve a major ambiguity.
4. **Correct Table 3**: Either restrict it to same-dataset comparisons only, or add an explicit column indicating which results were measured on the same dataset vs. different datasets, and remove the claim of "outperforming other methods on the same dataset" for the out-of-distribution baselines.
5. **Fix the confusion matrix labels**: Flip TP/TN labels in Table 2 so that "Loose" is the positive class (TP = correctly identified loose, TN = correctly identified control).
6. **Add U-Net as a segmentation baseline**: Run a standard U-Net with the same data split and loss function to demonstrate that the proposed architecture adds value beyond a widely available off-the-shelf segmentation model.

---

## Evaluation on Key Axes

- **Novelty**: Low-to-moderate. The zone-level task formulation and annotation are the primary novelty contributions. Individual network components (encoder-decoder segmentation, transfer-initialized classifier) are standard. No new architecture, loss function, or training paradigm is introduced.
- **Technical soundness**: Below average. The 5-fold CV vs. fixed split inconsistency, underspecified Stage 3 loss function, and inadequate Stage 1 evaluation are real methodological gaps.
- **Empirical support**: Weak. The headline 98% accuracy is on 57 test images with an inconsistent evaluation protocol; the comparison table mixes on-dataset and off-dataset baselines; no baseline comparison exists for the main segmentation task.
- **Significance**: Moderate in motivation; low in current demonstrated impact given the small dataset and evaluation issues.
- **Clarity**: Below average due to the evaluation protocol contradictions and ambiguous Stage 3 inference description.

---

## Score and Decision

**Calibration:**
- AAZ3vwyQ4X (4.0, Reject): MSPL paper — had a structural F1 metric flaw certifying degenerate results as near-perfect, unintelligible table rows, and no external baselines. That paper's methodology was more sophisticated but the evaluation framework was broken.
- 1F8xTfv6ah (5.5, Accept): KAN OOD paper — genuine empirical contributions with solid ImageNet results, overclaiming in abstract but core contribution was real and verifiable.

This paper is **below** AAZ3vwyQ4X (4.0). The MSPL paper had a stronger methodological core (the DRIAMS result was genuine even if the F1 metric was broken) and a more mature presentation. The present paper suffers from: (1) a dataset of 206 images which is extremely small even for applied medical imaging at ICLR, (2) an internal inconsistency (5-fold CV vs. 57-sample confusion matrix) that makes the primary headline result unverifiable, (3) a partially misleading comparison table, and (4) a core inference ambiguity. The clinical motivation is sound and the annotation contribution is genuine, but this work is more appropriate for a clinical informatics venue than ICLR, and it requires substantial methodological fixes before the central claims can be trusted.

**Score: 3.5 — Reject**

MY FINAL SCORE: <pineapple>3.5</pineapple>
MY FINAL DECISION: <orange>Reject</orange>